105 related articles for article (PubMed ID: 20059586)
1. Matrix metalloproteinase (MMP)-2 and MMP-9 activity and localization during ventral prostate atrophy and regrowth.
Justulin LA; Della-Coleta HH; Taboga SR; Felisbino SL
Int J Androl; 2010 Oct; 33(5):696-708. PubMed ID: 20059586
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
Justulin LA; Acquaro C; Carvalho RF; Silva MD; Felisbino SL
Int J Androl; 2010 Jun; 33(3):489-99. PubMed ID: 19490185
[TBL] [Abstract][Full Text] [Related]
3. Finasteride treatment alters MMP-2 and -9 gene expression and activity in the rat ventral prostate.
Delella FK; Justulin LA; Felisbino SL
Int J Androl; 2010 Feb; 33(1):e114-22. PubMed ID: 19508332
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-stromal transition of MMP-7 immunolocalization in the rat ventral prostate following bilateral orchiectomy.
Felisbino SL; Justulin Junior LA; Carvalho HF; Taboga SR
Cell Biol Int; 2007 Oct; 31(10):1173-8. PubMed ID: 17482841
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of developmental exposure to di-n-butyl-phthalate (DBP) on rat prostate: proliferative and inflammatory disorders and a possible role of androgens.
Scarano WR; Toledo FC; Guerra MT; de Campos SG; Júnior LA; Felisbino SL; Anselmo-Franci JA; Taboga SR; Kempinas Wde G
Toxicology; 2009 Aug; 262(3):215-23. PubMed ID: 19549552
[TBL] [Abstract][Full Text] [Related]
7. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
[TBL] [Abstract][Full Text] [Related]
9. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
[TBL] [Abstract][Full Text] [Related]
10. Expression of glutathione-peroxidase (GSH-PO) in the rat ventral prostate--effect of castration and administration of testosterone.
Murakoshi M; Ikeda R; Tagawa M; Suzuki M; Takekoshi S; Watanabe K
Tokai J Exp Clin Med; 1997 Sep; 22(3):111-8. PubMed ID: 9618832
[TBL] [Abstract][Full Text] [Related]
11. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
12. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
Simanainen U; McNamara K; Gao YR; Handelsman DJ
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1335-43. PubMed ID: 19366880
[TBL] [Abstract][Full Text] [Related]
13. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: change in cellular localization associated with high-grade prostatic intraepithelial neoplasia.
Upadhyay J; Shekarriz B; Nemeth JA; Dong Z; Cummings GD; Fridman R; Sakr W; Grignon DJ; Cher ML
Clin Cancer Res; 1999 Dec; 5(12):4105-10. PubMed ID: 10632347
[TBL] [Abstract][Full Text] [Related]
14. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
15. The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease.
Silva JA; Lorencini M; Peroni LA; De La Hoz CL; Carvalho HF; Stach-Machado DR
J Periodontal Res; 2008 Feb; 43(1):48-54. PubMed ID: 18230106
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
17. Short-term stromal alterations in the rat ventral prostate following alloxan-induced diabetes and the influence of insulin replacement.
Gobbo MG; Taboga SR; Ribeiro DL; Góes RM
Micron; 2012 Feb; 43(2-3):326-33. PubMed ID: 22014851
[TBL] [Abstract][Full Text] [Related]
18. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E
Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041
[TBL] [Abstract][Full Text] [Related]
19. Differential proliferative response of the ventral prostate and seminal vesicle to testosterone replacement.
Justulin LA; Ureshino RP; Zanoni M; Felisbino SL
Cell Biol Int; 2006 Apr; 30(4):354-64. PubMed ID: 16546411
[TBL] [Abstract][Full Text] [Related]
20. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
